Literature DB >> 17646732

Pituitary metastasis of breast cancer confirmed by fluorine-18 fluorodeoxyglucose positron emission tomography: a case report.

R Ersoy, O Topaloglu, C Aydin, A Dirikoc, B Cakir.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17646732     DOI: 10.1007/BF03346341

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  4 in total

1.  Standardized uptake values of normal breast tissue with 2-deoxy-2-[F-18]fluoro-D: -glucose positron emission tomography: variations with age, breast density, and menopausal status.

Authors:  Rakesh Kumar; Anil Chauhan; Hongming Zhuang; Prem Chandra; Mitchell Schnall; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2006 Nov-Dec       Impact factor: 3.488

2.  PET as a tool in the clinical evaluation of pituitary adenomas.

Authors:  M Bergström; C Muhr; P O Lundberg; B Långström
Journal:  J Nucl Med       Date:  1991-04       Impact factor: 10.057

3.  Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose.

Authors:  C K Hoh; R A Hawkins; J A Glaspy; M Dahlbom; N Y Tse; E J Hoffman; C Schiepers; Y Choi; S Rege; E Nitzsche
Journal:  J Comput Assist Tomogr       Date:  1993 Jul-Aug       Impact factor: 1.826

4.  A retrospective analysis of the impact of 18F-FDG PET scans on clinical management of 133 breast cancer patients.

Authors:  J F Y Santiago; M Gonen; H Yeung; H Macapinlac; S Larson
Journal:  Q J Nucl Med Mol Imaging       Date:  2006-03       Impact factor: 2.346

  4 in total
  2 in total

Review 1.  Clinical and biochemical characteristic features of metastatic cancer to the sella turcica: an analytical review.

Authors:  Ribal Al-Aridi; Katia El Sibai; Pingfu Fu; Mehreen Khan; Warren R Selman; Baha M Arafah
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

2.  Pituitary metastasis: a rare condition.

Authors:  Aida Javanbakht; Massimo D'Apuzzo; Behnam Badie; Behrouz Salehian
Journal:  Endocr Connect       Date:  2018-08-23       Impact factor: 3.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.